Hewlett Packard Enterprises (NYSE:HPE) unveiled HPE Ezmeral, a new software and brand portfolio designed to offer enterprises quick digital transformation from edge to cloud across the organization. HPE introduces HPE Ezmeral software portfolio The HPE Ezmeral software portfolio ranges from AI/ML and data analytics, container management, orchestration, AI-driven operations, IT Automation cost control, and security. […]
COVID-19
Alibaba Group Holding Ltd (NYSE:BABA) Handled The COVID-19 Crisis Better Than Amazon.com Inc. (NASDAQ:AMZN)
E-commerce giants Alibaba Group Holding Ltd (NYSE:BABA), Amazon.com Inc. (NASDAQ:AMZN), and JD.Com Inc. (NASDAQ:JD) have been on the spotlight regarding on how they have handled the COVID-19 crisis with some handling it better than others. Amazon drawing criticism on the handling of COVID-19 situation Although these e-commerce giants are different, all of them have nevertheless […]
Tesla CEO Elon Musk Calls For Breaking Up Amazon.com Inc. (NASDAQ:AMZN) After Censoring COVID-19 Book
On Thursday, Tesla Inc. (NASDAQ:TSLA) CEO, Elon Musk launched an attack on Amazon.com Inc. (NASDAQ:AMZN) calling for its breakup. This comes after Amazon censored Alex Berenson’s e-book about the wisdom behind the COVID-19 lockdowns. Musk calls out Amazon for censoring COVID-19 book In a Tweet, Musk said, “this is insane,” tagging Amazon CEO Jeff Bezos. […]
Gilead Sciences, Inc. (NASDAQ:GILD) Reports Minor Benefits Of Remdesivir In COVID-19 Patients
Gilead Sciences, Inc. (NASDAQ:GILD) released an update about its developmental COVID-19 vaccine remdesivir, revealing that the treatment yielded modest improvements in patients. Coronavirus patients who were administered with remdesivir intravenously for five days demonstrated moderate improvements. However, the COVID-19 patients that were treated with the drug for 10-days did not yield significant improvements. Remdesivir was […]
Virus Protection as an Investment Opportunity (CLX, HON, BLGO, MMM)
As we start to gain more ground in our collective battle against the COVID-19 pandemic, the role of personal protection equipment and supplies looms large as a major concept for investors active with capital and willing to mobilize that capital toward companies able to make a difference while delivering value to their shareholders. While we […]
Novavax, Inc (NASDAQ:NVAX) Chooses Australia For Its COVID-19 Clinical Trials
The deadly COVID-19 pandemic continues to affect lives globally, with many people hardly affording to pay their house rent. It is frustrating that until no scientific cure to help handle the condition has been established yet. However, any good efforts mean a lot to frustrated people globally. There are reports about another candidate that is […]
Is the PPE Theme Ready to Catch Fire? (APT, LAKE, BLGO, MMM)
The COVID-19 pandemic has forced a reimagining of life in the developed world to a far greater extent than most anything since World War II. As we endure this collective battle, there are few subjects that spark populist anger more than personal protection equipment (PPE) and its lack of availability for frontline workers – not […]
Moderna Inc. (NASDAQ:MRNA) Releases Positive Data For Its Coronavirus Vaccine Candidate In Human Trials
Moderna Inc. (NASDAQ:MRNA) has released positive data from its first human trials for its COVID-19 vaccine candidate, demonstrating that the healthy volunteers who received the vaccine developed antibody responses. Moderna’s vaccine in humans shows positive immunity response The company which had partnered with the National Institute of Health in developing the vaccine indicated that there […]
Abbott Laboratories’ (NYSE:ABT) ID NOW test May Be Giving Inaccurate Test Results Due To “User Error”
The US FDA has warned that Abbott Laboratories’ (NYSE:ABT) rapid COVID-19 test might be having accuracy issues that might be due to user error. The FDA cited various studies that have raised concerns about the test’s accuracy when employed in making a quick diagnosis. Abbott’s rapid test could be giving inaccurate results Alex Azar, the […]
Johnson & Johnson (NYSE:JNJ) Targets at least 1 Billion Vaccines in 2021
Johnson & Johnson (NYSE:JNJ) is working on a vaccine with a goal of 1 billion tests in 2021. According to Dr. Paul Stoffels, the Chief Scientific Officer at J&J, the company “is increasing its manufacturing and preparing for clinical trials in September.” The clinical trials should provide sufficient data to facilitate development of the vaccines […]
The Coronavirus Coping Portfolio (QDEL, GILD, QBIO, CYDY)
The COVID-19 pandemic has forced a dramatic realignment of social, cultural, and economic agendas because, in all cases, the healthcare issue has priority. It’s not a genuine public debate – if you don’t solve the healthcare crisis, you can’t solve any of the other crises that have been boiling over in the public discourse. That […]
Moderna, Inc. (NASDAQ: $MRNA), Q BioMed Inc (OTC: $QBIO) and Gilead Sciences (NASDAQ: $GILD) are getting a lot of attention now
Biotech stocks have continued to be market-leading targets for investors through the coronavirus stock market crash and rebound. Moderna, Inc. (NASDAQ: $MRNA), Q BioMed Inc (OTC: $QBIO) and Gilead Sciences (NASDAQ: $GILD) are getting a lot of attention now. Having been the first group to start testing a vaccine against SARS-CoV-2, Moderna inc (NASDAQ: MRNA) […]
Visa Inc. (NYSE:V) Puts Off US Interchange Fee Changes Until Next Year Because Of COVID-19
Visa Inc. (NYSE:V) has announced that it will delay expected US interchange changes and fees up to April next year. The company has cited disruptions due to the coronavirus pandemic for the postponement of the changes. Similarly, the company has confirmed a six-month delay of the EMV liability shift for gas owners for them to […]
Ford And Rivian Abandon Plans To Develop A Lincoln-Branded Electric Vehicle
The COVID-19 pandemic has caused major disruptions in business operations around the globe. The auto industry is also one of the many segments that have been hit hard. A joint project between Ford Motor Company (NYSE:F) and Rivian won’t go as had been planned. It was a deal that would see the two develop a […]
Gilead Sciences, Inc (NASDAQ:GILD) Speaks Out On The Trial Of Its Remdesivir Drug
Gilead Sciences, Inc (NASDAQ:GILD) is pleased to report about the success it is witnessing with its vaccine Remdesivir. The scientists have been working on the product in the hope that it would turn out to be the vaccine that would possibly help in dealing with COVID-19. Gilead has given an update outlining that it is […]
Recent Stories
How Pot Stocks Shape Up in H2 2020 (TLRY, LHSIF, NUGS, CURLF, APHA)
Seeking the Top Pot Stocks? (GTBIF, SGMD, MJNA, TCNNF)
Hewlett Packard Enterprises (NYSE:HPE) Introduces New HPE Ezmeral Brand And Software Portfolio And HPE GreenLake Cloud Service
CBD Stocks Gather Steam (CVSI, MJNA, MCTC, YCBD)
Cisco Systems Inc. (NASDAQ:CSCO) And Telenor (OTCMKTS:TELNY) Enhance Partnership To Provide Infrastructural Support To Telcos